GDF2 and hepatocellular carcinoma: Both drugs effectively increased the p‐MLC level in HUVECs pre‐incubated with BMP9‐overexpressing HBV‐infected cells to a level similar to that pre‐incubated with HBV‐infected hepatoma cells (Figure 5E,F, Supporting Information Figure S4C,D).